Email this article 
Epstein–Barr virus infection in patients after hematopoietic stem cells transplantation
- Authors: Balashov D.N.1,2, Shelikhova L.N.1,2, Demushkina A.A.2, Trakhtman P.E.1,2, Skorobogatova Y.V.1,2, Litvinov D.V.1,2, Raykina Y.V.1, Maschan A.A.1
-
Affiliations:
- Federal Research Center of Pediatric Hematology, Oncology and Immunology
- Russian Children Clinical Hospital
- Issue: No 3 (2010)
- Pages: 59-64
- Section: HEMATOPOIETIC STEM CELL TRANSPLANTATION
- Published: 26.08.2010
- URL: https://oncohematology.abvpress.ru/ongm/article/view/755
- ID: 755
Cite item
Full Text
Abstract
Epstein–Barr virus (EBV) is a member of herpes-viruses family. Now it is well-known, that it can be a cause of wide spectrum lymphoproliferative disoders. The given problem is especially serious after hematopoietic stem cells transplantation (HSCT); frequency of death linked to this complication can achieve 50–90 %. Risk factors for development of posttransplant lymphoproliferative syndromes (PTLS) are: using partially compatible graft, T-cell depletion, presence of severe acute graft-versus-host reaction (GVHD), using of antitymocytic globulin, etc. Severity of associated with EBV posttransplant complications and problems relate to absence of clear diagnostic algorithm, PTLS prophylactic and therapy schedule are argument for necessity of the further studies.
About the authors
D. N. Balashov
Federal Research Center of Pediatric Hematology, Oncology and Immunology; Russian Children Clinical Hospital
Author for correspondence.
Email: bala8@yandex.ru
Moscow
Russian FederationL. N. Shelikhova
Federal Research Center of Pediatric Hematology, Oncology and Immunology; Russian Children Clinical Hospital
Moscow
Russian FederationA. A. Demushkina
Russian Children Clinical Hospital
Moscow
Russian FederationP. E. Trakhtman
Federal Research Center of Pediatric Hematology, Oncology and Immunology; Russian Children Clinical Hospital
Moscow
Russian FederationYe. V. Skorobogatova
Federal Research Center of Pediatric Hematology, Oncology and Immunology; Russian Children Clinical Hospital
Moscow
Russian FederationD. V. Litvinov
Federal Research Center of Pediatric Hematology, Oncology and Immunology; Russian Children Clinical Hospital
Moscow
Russian FederationYe. V. Raykina
Federal Research Center of Pediatric Hematology, Oncology and Immunology
Moscow
Russian FederationA. A. Maschan
Federal Research Center of Pediatric Hematology, Oncology and Immunology
Moscow
Russian FederationReferences
Supplementary files
